Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
Stamatopoulos, K
Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia. [electronic resource] - Leukemia Jul 2008 - 1446-9 p. digital
Publication Type: Letter
1476-5551
10.1038/sj.leu.2405077 doi
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--adverse effects
Apoptosis
Bone Marrow--pathology
Cytokines--biosynthesis
Female
Hematopoiesis
Hematopoietic Stem Cells--physiology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphocyte Subsets--immunology
Lymphoma--drug therapy
Male
Middle Aged
Myelodysplastic Syndromes--pathology
Neutropenia--chemically induced
Rituximab
Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia. [electronic resource] - Leukemia Jul 2008 - 1446-9 p. digital
Publication Type: Letter
1476-5551
10.1038/sj.leu.2405077 doi
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--adverse effects
Apoptosis
Bone Marrow--pathology
Cytokines--biosynthesis
Female
Hematopoiesis
Hematopoietic Stem Cells--physiology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphocyte Subsets--immunology
Lymphoma--drug therapy
Male
Middle Aged
Myelodysplastic Syndromes--pathology
Neutropenia--chemically induced
Rituximab